Trial Profile
Phase 2 Clinical Trial of CRLX101 in Relapsed Ovarian Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Jun 2014
Price :
$35
*
At a glance
- Drugs Camptothecin (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- Sponsors Cerulean Pharma
- 10 Jun 2014 New trial record